CY 2027 RPM/RTM Vendor Business-Model Transition Assessment
A vendor-side strategy engagement, not the provider diagnostic. If CMS finalizes the proposed employment restriction, it answers which revenue and customer segments depend on affected RPM/RTM clinical staffing, which customer configurations can transition, and what the 2027 operating model should become. The rule is proposed, not final.
Discuss Vendor Transition StrategyWho it's for
RPM/RTM technology and full-service vendors; CEO, COO, strategy, commercial, and finance leadership.
Based on
CMS-1848-P proposed policy, vendor revenue and delivery architecture, customer operating-model configurations, and staffing and product dependencies supplied by the organization.
Why it matters
A payment-eligibility change in the clinical work can reshape a vendor's revenue mix, delivery model, and commercial positioning well before customers act.
What we analyze
Affected revenue-stream mapping; customer segmentation by operating model; separation of RPM/RTM from CCM/APCM; product and service architecture exposure; staffing alternatives; SaaS and technology migration feasibility; revenue-retention scenarios; commercial repositioning; customer-transition roadmap; final-rule scenarios.
What you receive
Revenue exposure and segmentation analysis, operating-model options, revenue-retention scenarios, commercial positioning direction, and a customer-transition roadmap. No legal opinions or contract interpretation.
Format
Enterprise strategy assessment.
Investment
contact us for pricing; Tiers include-Focused /enterprise /Final-rule refresh
Discuss this engagement
Tell us about the organization and the decision you are facing. We will confirm the scope before work begins.